BioSpace News Archive

Foresee Pharmaceuticals Co., Ltd. (6576.TWO) today announced that all patients had completed participation in its Phase 3, multinational, multicenter trial of FP-001/LMIS (Leuprolide Mesylate Injectable Suspension) 25 mg, a three-month, ready-to-use subcutaneous depot formulation for the treatment of advanced prostate cancer.

With these hires, Arena will be expanding its footprint into the Boston area.

Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today updates the regulatory and peer-review publication status of Ampion.

Mr. Panuwat will serve on the executive leadership team and will lead business and corporate development for ORIC.

The solution integrates with existing MRI scanners and leverages Artificial Intelligence and Machine Learning to complete a comprehensive ischemia exam in less than 15 minutes

Focusing on Business Diversification Strategies and Achieved Double-Digit Group Revenue Growth

Trainings will be conducted for staff and customers of Laboratorios Franja, followed by launch of Company’s products in DR

Sutro Biopharma, Inc. will present at the 30th Annual Piper Jaffray Healthcare Conference.

New 3T MR Software Features Showcased at RSNA 2018

Expanding its advanced, high-performing AplioTM i-series ultrasound platform, today Canon Medical Systems USA, Inc. introduces the industry’s first 33 MHz ultra-high frequency linear iDMS transducer, providing extremely fine detail in the near field and the highest frequency on the market.